Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx
- PMID: 20015735
- DOI: 10.1016/j.amjoto.2008.12.004
Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx
Abstract
Purpose: The aim of the present study was to compare the incidence, patterns, and survival of second primary malignancy (SPM) in patients with squamous cell carcinoma of the larynx (LSCC) and hypopharynx (HPSCC).
Methods: We retrospectively review the medical record of 581 previously untreated patients with LSCC (392 cases) and HPSCC (189 cases) who received primary surgery with or without postoperative radiotherapy from 1990 to 2000. Data including age, sex, risk factors, subsites and TNM stage of primary tumor, treatment, site and incidence of SPM, and prognosis were collected from medical charts.
Results: Groups with HPSCC had a higher incidence (4.2% vs 2.9% annual rate) and shorter median time (30 vs 59 months) developing SPM rather than LSCC. Fifty-five percent of the SPM occurred in the respiratory axis in LSCC, and 66% developed in the digestive axis in HPSCC. The factors influencing the appearance of SPM included early T stage, tobacco use, and less tumor recurrence. Long-term survival was poorer in those with than without SPM (38% vs 49% at 10 years).
Conclusions: There is a tendency for SPM to occur in the respiratory axis (lung and larynx) in LSCC and in the digestive axis (oral cavity, pharynx, and esophagus) in HPSCC. This information is important for posttreatment follow-up.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study.Acta Otolaryngol. 2009 Dec;129(12):1480-5. doi: 10.3109/00016480902748520. Acta Otolaryngol. 2009. PMID: 19922101
-
Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.Laryngoscope. 2001 Jun;111(6):1079-87. doi: 10.1097/00005537-200106000-00028. Laryngoscope. 2001. PMID: 11404625
-
Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.Hepatogastroenterology. 1994 Jun;41(3):278-82. Hepatogastroenterology. 1994. PMID: 7959554 Clinical Trial.
-
Risk factors involved in stomal recurrence following laryngectomy.J Laryngol Otol. 1993 Jun;107(6):527-31. doi: 10.1017/s0022215100123618. J Laryngol Otol. 1993. PMID: 8345300 Review.
-
The incidence of cancer of the larynx.Clin Otolaryngol Allied Sci. 1991 Apr;16(2):198-201. doi: 10.1111/j.1365-2273.1991.tb01976.x. Clin Otolaryngol Allied Sci. 1991. PMID: 2070539 Review. No abstract available.
Cited by
-
Treatment Modality and Second Primary Tumors of the Head and Neck.ORL J Otorhinolaryngol Relat Spec. 2021;83(6):420-427. doi: 10.1159/000513617. Epub 2021 Sep 29. ORL J Otorhinolaryngol Relat Spec. 2021. PMID: 34587611 Free PMC article.
-
Long-Term Care and Follow-Up in Laryngeal Cancer Patients: A Multicenter Retrospective Analysis.J Pers Med. 2023 May 31;13(6):927. doi: 10.3390/jpm13060927. J Pers Med. 2023. PMID: 37373916 Free PMC article.
-
Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients.Esophagus. 2024 Apr;21(2):131-140. doi: 10.1007/s10388-023-01039-3. Epub 2024 Jan 9. Esophagus. 2024. PMID: 38194013
-
Causes of death of patients with laryngeal cancer.Eur Arch Otorhinolaryngol. 2014 Mar;271(3):425-34. doi: 10.1007/s00405-013-2478-0. Epub 2013 Apr 17. Eur Arch Otorhinolaryngol. 2014. PMID: 23591796 Review.
-
Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis.Oncotarget. 2015 Oct 6;6(30):29268-84. doi: 10.18632/oncotarget.4922. Oncotarget. 2015. PMID: 26337468 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources